97-4227. Agency Information Collection Activities; Submission for OMB Review; Comment Request  

  • [Federal Register Volume 62, Number 35 (Friday, February 21, 1997)]
    [Notices]
    [Page 8024]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-4227]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Food and Drug Administration
    [Docket No. 97N-0025]
    
    
    Agency Information Collection Activities; Submission for OMB 
    Review; Comment Request
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing that the 
    proposed collection of information listed below has been submitted to 
    the Office of Management and Budget (OMB) for review and clearance 
    under the Paperwork Reduction Act of 1995.
    
    DATES: Submit written comments on the collection of information by 
    March 24, 1997.
    
    ADDRESSES: Submit written comments on the collection of information to 
    the Office of Information and Regulatory Affairs, OMB, New Executive 
    Office Bldg., 725 17th St. NW., rm. 10235, Washington, DC 20503, Attn: 
    Desk Officer for FDA.
    
    FOR FURTHER INFORMATION CONTACT: Margaret R. Wolff, Office of 
    Information Resources Management (HFA-250), Food and Drug 
    Administration, 5600 Fishers Lane, rm. 16B-19, Rockville, MD 20857, 
    301-827-1223.
    
    SUPPLEMENTARY INFORMATION: In compliance with section 3507 of the 
    Paperwork Reduction Act of 1995 (44 U.S.C. 3507), FDA has submitted the 
    following proposed collection of information to OMB for review and 
    clearance:
    
    Medical Devices Standards Activities Report (OMB Control Number 
    0910-0219--Extension)
    
        FDA is collecting information necessary to update a comprehensive 
    listing of current national and international standards activities in 
    the field of medical devices. The collection of this information is 
    authorized by section 514(a)(4)(B) of the Federal Food, Drug, and 
    Cosmetic Act (21 U.S.C. 360d(a)(4)(B)), which requires FDA to consult 
    with other nationally or internationally recognized standard-setting 
    entities, including other Federal agencies concerned with standard-
    setting, in carrying out its responsibility to establish special 
    controls for medical devices. This report is used by approximately 39 
    standards-developing organizations to coordinate their standards 
    activities. This coordination prevents duplication of effort and 
    insures efficient and expeditious management of standards development. 
    Over 700 copies of this report are used by government, hospitals, 
    libraries, industry, private citizens, and State and local government 
    agencies, including FDA, to keep abreast of standards development 
    activities and current technology concerning the safety of medical 
    devices. Without the report, there would be duplication of standards 
    efforts by voluntary standards organizations because there is no other 
    publication that can be easily referenced to ascertain if a certain 
    medical device standard is being or has been developed.
        FDA estimates the burden of this collection of information as 
    follows:
    
                        Estimated Annual Reporting Burden                   
    ------------------------------------------------------------------------
                         Annual                                             
         No. of      Frequency per   Total Annual    Hours per   Total Hours
      Respondents       Response      Responses      Response               
    ------------------------------------------------------------------------
    39.............         0.5           19.5             3          58.5  
    ------------------------------------------------------------------------
    There are no capital costs or operating and maintenance costs associated
      with this collection of information.                                  
    
        This collection occurs biennially and is voluntary. There are 39 
    national and international organizations with one report each reporting 
    period.
    
        Dated: February 12, 1997.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 97-4227 Filed 2-20-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
02/21/1997
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
97-4227
Dates:
Submit written comments on the collection of information by March 24, 1997.
Pages:
8024-8024 (1 pages)
Docket Numbers:
Docket No. 97N-0025
PDF File:
97-4227.pdf